Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Current Opinion in Allergy and Clinical Immunology|October 1, 2019
Clozapine-associated secondary antibody deficiencyMark J Ponsford, Antonio Pecoraro, Stephen Jolles
Frontiers in Immunology|March 19, 2020
Heterogeneity of Liver Disease in Common Variable Immunodeficiency DisordersAntonio Pecoraro, Ludovica Crescenzi, Gilda Varricchi, et al.
International Immunopharmacology|September 13, 2017
Immunoglobulin replacement therapy in primary and secondary antibody deficiency: The correct clinical approachAntonio Pecoraro, Ludovica Crescenzi, Francescopaolo Granata, et al.
International Immunopharmacology|February 3, 2017
Heart failure not responsive to standard immunosuppressive therapy is successfully treated with high dose intravenous immunoglobulin therapy in a patient with Eosinophilic Granulomatosis with Polyangiitis (EGPA)Antonio Pecoraro, Ludovica Crescenzi, Laura Carucci, et al.
Clinical Drug Investigation|February 10, 2020
Correlations Among Subcutaneous Immunoglobulin Dosage, Immunoglobulin G Serum Pre-infusional Levels and Body Mass Index in Primary Antibody Deficiency Patients: A Pooled Analysis from the SHIFT/IBIS StudiesAntonio Pecoraro, Silvia Ricci, Alessandra Vultaggio, et al.
Clinical Immunology (Orlando, Fla.)|April 12, 2016
Intravenous versus subcutaneous immunoglobulin replacement in secondary hypogammaglobulinemiaGiuseppe Spadaro, Antonio Pecoraro, Amalia De Renzo, et al.
Ageing Research Reviews|April 29, 2020
The emerging role of T follicular helper (T<sub>FH</sub>) cells in aging: Influence on the immune frailtyGilda Varricchi, Leonardo Bencivenga, Remo Poto, et al.
Journal of Clinical Immunology|November 16, 2017
Chronic Diarrhea in Common Variable Immunodeficiency: a Case Series and Review of the LiteratureAntonio Pecoraro, Liliana Nappi, Ludovica Crescenzi, et al.
Frontiers in Immunology|July 31, 2018
Thymic Stromal Lymphopoietin Isoforms, Inflammatory Disorders, and CancerGilda Varricchi, Antonio Pecoraro, Giancarlo Marone, et al.
Expert Opinion on Investigational Drugs|December 5, 2018
Prostaglandin D<sub>2</sub> receptor antagonists in allergic disorders: safety, efficacy, and future perspectivesGiancarlo Marone, Maria Rosaria Galdiero, Antonio Pecoraro, et al.
Pageof 4